{"id":489192,"date":"2020-06-09T18:00:01","date_gmt":"2020-06-09T18:00:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=489192"},"modified":"2020-06-09T18:00:01","modified_gmt":"2020-06-09T18:00:01","slug":"singlecell-analysis-market-worth-56-billion-by-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/singlecell-analysis-market-worth-56-billion-by-2025_489192.html","title":{"rendered":"Single-cell Analysis Market Worth $5.6 Billion by 2025"},"content":{"rendered":"
\"Single-cell<\/a><\/p>\n
\n
Prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US)<\/div>\n<\/div>\n<\/div>\n
The research applications segment accounted for the largest market share in 2018. Increasing government initiatives in stem cell research and the wide usage of single-cell analysis in cancer research are the major factors driving the growth of the research applications segment.<\/div>\n

According to the new market research report “<\/strong>Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User – Global Forecasts to 2025″<\/strong>, published by MarketsandMarkets™, the Single-cell Analysis Market is projected to reach USD 5.6 billion<\/span> by 2025 from USD 2.1 billion<\/span> in 2019, at a CAGR of 17.8% during the forecast period.<\/p>\n

Download PDF Brochure:<\/strong>
https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=171955254<\/a><\/p>\n

The growth in this market is driven by technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and the increasing incidence and prevalence of chronic and infectious diseases. However, the high cost of single-cell analysis products is expected to restrain the growth of this market to a certain extent during the forecast period. <\/p>\n

\"single-cell-analysis-market3\"<\/p>\n

<\/strong>The research applications segment accounted for the largest share of the market, by application, in 2018<\/p>\n

<\/strong>Based on application, the Single-cell Analysis Market is segmented into research (cancer, immunology, neurology, stem cell, and other research applications) and medical applications (noninvasive prenatal diagnosis, in vitro fertilization, and circulating tumor cell detection). The research applications segment accounted for the largest share of the market in 2018. Increasing government initiatives in stem cell research and the wide usage of single-cell analysis in cancer research are the major factors driving the growth of the research applications segment.<\/p>\n

Browse in-depth TOC on<\/em> “<\/strong>Single-cell Analysis Market<\/a>“<\/p>\n

<\/strong>225 – Tables
<\/strong>50 – Figures  
<\/strong>252 – Pages<\/p>\n

<\/strong>The flow cytometry segment accounted for the largest market share in 2018<\/p>\n

<\/strong>Based on technique, the market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques. The flow cytometry segment accounted for the largest market share in 2018. The large share of this segment is attributed to the wide usage of flow cytometry in detecting and measuring the physical and chemical characteristics of a population of cells or particles. However, the NGS segment is projected to register the highest growth rate during the forecast period. The high growth of the NGS segment is driven by the increasing application of single-cell analysis products in drug discovery for cancer and other chronic diseases.<\/p>\n

Request Sample Pages:<\/strong>
https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=171955254<\/a> <\/p>\n

North America<\/span> dominates the Single-cell Analysis Market<\/p>\n

<\/strong>The global market is segmented into five major regions, namely, North America<\/span>, Europe<\/span>, Asia Pacific<\/span>, Latin America<\/span>, and the Middle East<\/span> & Africa<\/span>. In 2018, North America<\/span> accounted for the largest share of the market. The growth in this market can be attributed to the increasing drug development activities in the pharmaceutical and biotechnology industries, rising prevalence of chronic and infectious diseases, and an increase in stem cell research activities.<\/p>\n

Prominent players in the Single-cell Analysis Market include Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands<\/span>), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US), Promega Corporation (US), Illumina (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies (US), NanoString Technologies (US), Tecan Group (Switzerland<\/span>), Sartorius AG (Germany<\/span>), Luminex Corporation (US), Takara Bio<\/span> (Japan<\/span>), Fluxion Biosciences (US), Menarini Silicon Biosystems (Italy<\/span>), and LumaCyte (US).<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/single-cell-analysis-market-171955254.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US) The research applications segment accounted for the largest … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,404,416],"tags":[],"class_list":["post-489192","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/489192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=489192"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/489192\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=489192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=489192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=489192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}